Bellidifolin

Bellidifolin
Product Name Bellidifolin
CAS No.: 2798-25-6
Catalog No.: CFN89132
Molecular Formula: C14H10O6
Molecular Weight: 274.22 g/mol
Purity: >=98%
Type of Compound: Xanthones
Physical Desc.: Powder
Targets: ERK | p38MAPK | Caspase | ROS | PI3K | LDL | MAO
Source: The plants of Gentiana species.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $268/10mg
Bellidifolin has anti-oxidation, hepatoprotective, anti-inflammatory and antitumor actions, it may contribute to the protective effects associated with nerve injury initiated by hypoxia by mechanisms related to inhibition of cell apoptosis independent of the ERK pathway. Bellidifolin shows interesting inhibitory activity of monoamine oxidases (MAO) A, it could be useful for treating type-2 diabetes, likely via the improvement of insulin resistance (IR). Bellidifolin also shows an antifungal effect (MIC values of 50 microg/mL).
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Nat Commun.2023, 14(1):5075.
  • Eur Rev Med Pharmacol Sci.2020, 24(9):5127-5139.
  • Journal of Food Hygiene and Safety2019, 34(5):413-420
  • J Applied Biological Chemistry2021, 64(2):185-192
  • Int J Mol Sci.2022, 23(21):13112.
  • BMC Complement Med Ther.2023, 23(1):264.
  • Institute of Food Science & Technology2021, 45(9).
  • Food Bioscience2022, 50:102187.
  • Institut Pasteur Korea2020, doi: 10.21203.
  • Mol Plant Pathol.2023, 24(2):123-141.
  • Bellidifolin

    Catalog No: CFN89132
    CAS No: 2798-25-6
    Price: $268/10mg
    Gentisein

    Catalog No: CFN92398
    CAS No: 529-49-7
    Price: Inquiry(manager@chemfaces.com)
    1,3,5-Trihydroxyxanthone

    Catalog No: CFN92399
    CAS No: 6732-85-0
    Price: Inquiry(manager@chemfaces.com)
    1,3,5,6-Tetrahydroxyxanthone

    Catalog No: CFN92539
    CAS No: 5084-31-1
    Price: Inquiry(manager@chemfaces.com)
    1,3,6-Trihydroxy-5-methoxyxanthone

    Catalog No: CFN92540
    CAS No: 41357-84-0
    Price: Inquiry(manager@chemfaces.com)
    3,8-Dihydroxy-2,4,6-trimethoxyxanthone

    Catalog No: CFN92556
    CAS No: 65008-17-5
    Price: Inquiry(manager@chemfaces.com)
    1,6,7-Trihydroxyxanthone

    Catalog No: CFN98284
    CAS No: 25577-04-2
    Price: Inquiry(manager@chemfaces.com)
    Norathyriol

    Catalog No: CFN98468
    CAS No: 3542-72-1
    Price: $368/5mg
    Montixanthone

    Catalog No: CFN91903
    CAS No: 876305-36-1
    Price: Inquiry(manager@chemfaces.com)
    3,6-Dihydroxy-1,7-dimethoxyxanthone

    Catalog No: CFN89303
    CAS No: 262292-34-2
    Price: Inquiry(manager@chemfaces.com)
    J Ethnopharmacol. 2014 May 14;153(3):854-63.
    Two xanthones from Swertia punicea with hepatoprotective activities in vitro and in vivo.[Pubmed: 24690777 ]
    Swertia punicea Hemsl. (Gentianaceae) is more commonly known as "Ganyan-cao" and used mainly as a traditional Chinese folk medicine for the treatment of acute bilious hepatitis, cholecystitis, fever, intoxification and jaundice.
    METHODS AND RESULTS:
    The active hepatoprotective constituents of Swertia punicea were purified using various column chromatography techniques. The structures of two isolated compounds were determined on the basis of spectroscopic data interpretation such as NMR analysis. The hepatoprotective activities of isolated compounds were evaluated by using hepatotoxicity in vitro and dimethylnitrosamine-induced rat hepatic fibrosis in vivo, respectively. Two xanthones, 1, 7-dihydroxy-3, 4, 8-trimethoxyxanthone (1) and Bellidifolin (2) were isolated from the stems of Swertia punicea. The compounds 1 and 2 exhibited notable hepatoprotective activities against carbon tetrachloride (CCl4) -induced HepG2 cell damage, and effectively alleviated the levels of aspartate transaminase (AST), lactate dehydrogenase (LDH), superoxide dismutase (SOD) and malonic dialdehyde (MDA) induced by CCl₄ in a concentration-dependent manner. Co-treatment with compound 2 significantly increased the cell viability compared with N-acetyl-p-aminophenol (APAP) treatment. Compound 2 also alleviated APAP-induced hepatotoxicity by increasing glutathione (GSH) content and decreasing hydroxyl free radical (·OH) levels and reactive oxygen specises (ROS) production. In addition, the protective effect of compound 1 significantly alleviated DMN-induced liver inflammation and fibrosis. Oral administration of compound 1 recovered the reduction of albumin (ALB) and reversed the elevation of serum alanine transaminase (ALT), AST and total bilirubin (TBIL) in dimethylnitrosamine (DMN)-induced fibrotic rats. Severe oxidative stress induced in fibrotic rats was evidenced by a 1.5-fold elevation in MDA and a fall in the SOD activity, and treatment with compound 1 protected against these adverse effects. Recovery of rat liver tissue against DMN-induced hepatocellular necrosis, inflammatory changes and hepatic fibrosis by compound 1 is also confirmed by H&E and Masson stained histopathological evaluation of liver tissue.
    CONCLUSIONS:
    Two xanthones from Swertia punicea exhibited hepatoprotective activities in vitro (compounds 1 and 2) and in vivo (compound 1), respectively.
    Z Naturforsch C. 2012 Jan-Feb;67(1-2):29-38.
    Antimicrobial and antioxidant activities of Gentianella multicaulis collected on the Andean Slopes of San Juan Province, Argentina.[Pubmed: 22486039]
    The infusion of the aerial parts of Gentianella multicaulis (Gillies ex Griseb.) Fabris (Gentianaceae), locally known as 'nencia', is used in San Juan Province, Argentina, as stomachic and as a bitter tonic against digestive and liver problems.
    METHODS AND RESULTS:
    The bioassay-guided isolation of G. multicaulis extracts and structural elucidation of the main compounds responsible for the antifungal and free radical scavenging activities were performed. The extracts had strong free radical scavenging effects in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay (45-93% at 10 microg/mL) and ferric-reducing antioxidant power (FRAP) assay at 200 microg/mL. DemethylBellidifolin (4) had high antioxidant activity in the DPPH and FRAP assay. The dermatophytes Microsporum gypseum, Trichophyton mentagrophytes, and T. rubrum were moderately inhibited by the different extracts (MIC values of 125-250 microg/mL). DemethylBellidifolin (4), Bellidifolin (5), and isoBellidifolin (6) showed an antifungal effect (MIC values of 50 microg/mL), while swerchirin (3) was less active with a MIC value of 100 microg/mL. In addition, oleanolic acid (1) and ursolic acid (2) were also isolated.
    CONCLUSIONS:
    These findings demonstrate that Gentianella multicaulis collected in the mountains of the Province of San Juan, Argentina, is an important source of compounds with antifungal and antioxidant activities.
    Phytomedicine. 2010 Jun;17(7):533-9.
    Anti-diabetic effect of methylswertianin and bellidifolin from Swertia punicea Hemsl. and its potential mechanism.[Pubmed: 19962285 ]

    METHODS AND RESULTS:
    In this study, we continued to investigate the hypoglycemic activity of Swertia punicea Helmsl., the hypoglycemic and hypolipidemic effects of methylswertianin and Bellidifolin from the active ethyl acetate (EtOAc) fraction, and the potential mechanism(s) underlying the improvement of insulin resistance. Streptozotocin (STZ)-induced type 2 diabetic male BABL/c mice treated with methylswertianin and Bellidifolin at different doses (orally, 200 and 100mg/kg body wt./day) for 4 weeks were analyzed in comparison to untreated mice. The results proved that methylswertianin and Bellidifolin significantly reduced fasting blood glucose (FBG). The administration of both compounds also improved the oral glucose tolerance and lowered fasting serum insulin (FINS). Moreover, post-administration evaluation revealed lower serum total cholesterol (TC), low density lipoprotein cholesterol (LDL) and triglyceride (TG) levels and increased relative high density lipoprotein cholesterol (HDL) concentrations (HDL/TC). Methylswertianin and Bellidifolin appeared to improve insulin resistance by enhancing insulin signaling. The expression levels of insulin-receptor alpha subunit (InsR-alpha), insulin-receptor substrate-1 (IRS-1), and phosphatidylinositol 3-kinase (PI3K) were also increased after administration. Meanwhile, methylswertianin and Bellidifolin increased hepatic glycogen content, decreased glucokinase (GK) activities and increased glucose-6-phosphatase (G6Pase) activities.
    CONCLUSIONS:
    In conclusion, these result indicated that methylswertianin and Bellidifolin could be useful for treating type-2 diabetes, likely via the improvement of insulin resistance (IR).
    J Toxicol Environ Health A. 2017 Sep 12:1-6.
    Protective effects of bellidifolin in hypoxia-induced in pheochromocytoma cells (PC12) and underlying mechanisms.[Pubmed: 28895799 ]
    Bellidifolin, a xanthone compound derived from plants of Gentiana species, is known to exert a variety of pharmacological activities including anti-oxidation, anti-inflammatory and antitumor actions as well as a protective effect on cerebral ischemic nerve injury.
    METHODS AND RESULTS:
    The aim of this study was to examine the protective effects of Bellidifolin on nerve injury produced by hypoxia and possible underlying mechanisms using pheochromocytoma cells (PC12). Data showed that the viability of PC12 cells subjected to hypoxia resulted in a significant decrease; however; pretreatment with certain concentrations of Bellidifolin (20 or 40 μmol/L) prior to hypoxia significantly increased the survival rate. The results of immunohistochemical staining analysis revealed that there were no marked alterations in the expression of pERK protein between all Bellidifolin groups while the expression of p-p38MAPK protein was significantly enhanced by hypoxia. Pretreatment with different concentrations of Bellidifolin followed by hypoxia significantly decreased the expression of p-p38MAPK protein. The results of western blot analysis showed that hypoxia induced the expression of the MAPK signaling pathway downstream of the key apoptosis factor caspase-3. Compared to hypoxia, the expression of caspase-3 in the presence of belliidifolin was significantly lower.
    CONCLUSIONS:
    Data suggest that Bellidifolin may contribute to the protective effects associated with nerve injury initiated by hypoxia by mechanisms related to inhibition of cell apoptosis independent of the ERK pathway, but may involve blockade of p38MAPK signaling pathway activation and downstream caspase-3 expression.
    J Nat Prod. 2008 May;71(5):895-7.
    Xanthones from Gentianella amarella ssp. acuta with acetylcholinesterase and monoamine oxidase inhibitory activities.[Pubmed: 18336006 ]
    Two new xanthone glycosides, corymbiferin 3-O-beta-D-glucopyranoside (1) and swertiabisxanthone-I 8'-O-beta- d-glucopyranoside (2), were isolated from Gentianella amarella ssp. acuta, along with eight known xanthones: triptexanthoside C, veratriloside, corymbiferin 1-O-glucoside, swertianolin, norswertianolin, swertiabisxanthone-I, bellidin, and Bellidifolin, four of them identified for the first time in G. amarella ssp. acuta.
    METHODS AND RESULTS:
    The isolation was conducted mainly by centrifugal partition chromatography, and the structures of the isolated compounds were established on the basis of spectrometric data including 2D NMR and mass spectrometry. Xanthones were weakly active against acetylcholinesterase (AChE), except triptexanthoside C, which inhibited AChE with an IC(50) of 13.8 +/- 1.6 microM.
    CONCLUSIONS:
    Some compounds were active against monoamine oxidases (MAO): bellidin and Bellidifolin showed interesting inhibitory activity of MAO A, while swertianolin, the 8-O-glucopyranoside form of Bellidifolin, gave 93.6% inhibition of MAO B activity at 10(-5) M.
    20-O-Glucoginsenoside Rf

    Catalog No: CFN95036
    CAS No: 68406-27-9
    Price: $318/5mg
    3''-O-Galloylmyricitrin

    Catalog No: CFN95057
    CAS No: 143202-36-2
    Price: $333/5mg
    Methyl lucidenate G

    Catalog No: CFN95058
    CAS No: 102607-20-5
    Price: $413/5mg
    N-Methylcorydalmine

    Catalog No: CFN95204
    CAS No: 81010-29-9
    Price: $398/5mg
    Quasipanaxatriol

    Catalog No: CFN95248
    CAS No: 171903-78-9
    Price: $413/5mg
    N-trans-caffeoyloctopamine

    Catalog No: CFN95264
    CAS No: 1378868-10-0
    Price: $413/5mg
    New compound 8

    Catalog No: CFN95341
    CAS No: N/A
    Price: $318/5mg
    Murracarpin

    Catalog No: CFN95409
    CAS No: 120786-76-7
    Price: $413/5mg
    Citrusin C

    Catalog No: CFN95420
    CAS No: 18604-50-7
    Price: $318/10mg
    Clinopodic acid E

    Catalog No: CFN95595
    CAS No: 159736-38-6
    Price: $318/5mg